Evidence indicates that MTA3 expression is significantly downregulated in GEJ adenocarcinoma tissues and highly metastatic cell lines, including OE-19 and FLO-1 (51). The gene discussed is MTA3; the disease is gastroesophageal junction adenocarcinoma.